Oxidative stress status in metastatic breast cancer patients receiving palliative chemotherapy and its impact on survival rates

Free Radical Research

Volumn 46, Issue 1, 2012, Pages 2-10

  Vera Ramirez, Laura ^a,b   Sanchez Rovira, Pedro ^a,b   Ramirez Tortosa, M Carmen ^b,c   Ramirez Tortosa, Cesar L ^a   Granados Principal, Sergio ^b,c   Lorente, Jose A ^b   Quiles, Jose L ^b,c  

^a Complejo Hospitalario de Jaen ^*  (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c Biomedical Research Center CIBM   (Spain)

Author keywords

Disease free survival; DNA oxidation; DNA repair; Metastasis; Plasma antioxidants

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; DEOXYRIBONUCLEOPROTEIN; KU86 PROTEIN; MONOCLONAL ANTIBODY; REPLICATION FACTOR A; TAXANE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DNA DETERMINATION; DNA REPAIR; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; OXIDATIVE STRESS; SURVIVAL RATE;

ADULT; AGED; ANTIGENS, NUCLEAR; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DNA REPAIR; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; OXIDATIVE STRESS; PALLIATIVE CARE; SURVIVAL RATE;

EID: 83055178936     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2011.635658     Document Type: Article

References (34)

1. Parkin DM, Fern án dez LMG. Use of statistics to assess the global burden of breast cancer. Breast J 2006;12:S70-80. (Pubitemid 43385274)
2. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-592. (Pubitemid 46359643)
3. Bines J, Eniu A. Effective but cost-prohibitive drugs in breast cancer treatment: a clinician ' s perspective. Cancer 2008;113:2353-2358.
4. Kopjar N, Milas L, Garaj-Vrhovac V, Gamulin M. Alkaline comet assay study with breast cancer patients: evaluation of baseline and chemotherapy-induced DNA damage in nontarget cells. Clin Exp Med 2006;6:177-190. (Pubitemid 46025592)
5. Conklin KA. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 2004;3:294-300. (Pubitemid 39552423)
6. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;44:1-40. (Pubitemid 43227479)
7. Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa MC, Ramirez-Tortosa CL, Granados-Principal S, Lorente JA, Quiles JL. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. Crit Rev Oncol Hematol 2011; 80:347-368.
8. Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem J 2007;401:1-11. (Pubitemid 46115897)
9. Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa M, et al. Does chemotherapy-induced oxidative stress improve the survival rates of breast cancer patients? Antioxid Redox Signal 2011;15:903-909.
10. Fornier MN. Approved agents for metastatic breast cancer. Semin Oncol 2011;38:S3-10.
11. Duthie SJ, Ma A, Ross MA, Collins AR. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res 1996;56:1291-1295. (Pubitemid 26080971)
12. Duthie SJ, Hawdon A. DNA stability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J 1998;12:1491-1497. (Pubitemid 28506718)
13. Ochoa JJ, Quiles JL, Ramirez-Tortosa MC, Mataix J, Huertas JR. Dietary oils high in oleic acid but with different unsaponifi able fraction contents have different effects in fatty acid composition and peroxidation in rabbit LDL. Nutrition 2002;18:60-65. (Pubitemid 34097715)
14. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999;26:1231-1237. (Pubitemid 29262709)
15. Fisher LD, Lin DY. Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 1999;20:145-157. (Pubitemid 29242575)
16. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004;56:185-229. (Pubitemid 38720829)
17. Demirbag R, Yilmaz R, Erel O. The association of total antioxidant capacity with sex hormones. Scand Cardiovasc J 2005;39:172-176. (Pubitemid 41657528)
18. Perumal SS, Shanthi P, Sachdanandam P. Augmented effi cacy of tamoxifen in rat breast tumorigenesis when gavaged along with ribofl avin, niacin, and CoQ10: effects on lipid peroxidation and antioxidants in mitochondria. Chem Biol Interact 2005;152:49-58. (Pubitemid 40568631)
19. Bhatti P, Sigurdson AJ, Thomas CB, et al. No evidence for differences in DNA damage assessed before and after a cancer diagnosis. Cancer Epidemiol Biomarkers Prev 2008;17: 990-994. (Pubitemid 351536435)
20. Colleu-Durel S, Guitton N, Nourgalieva K, et al. Alkaline single-cell gel electrophoresis (comet assay): a simple technique to show genomic instability in sporadic breast cancer. Eur J Cancer 2004;40:445-451. (Pubitemid 38121283)
21. Hussien MMI, McNulty H, Armstrong N, Johnston PG, Spence RAJ, Barnett Y. Investigation of systemic folate status, impact of alcohol intake and levels of DNA damage in mononuclear cells of breast cancer patients. Br J Cancer 2005;92:1524-1530. (Pubitemid 40705021)
22. Sánchez-Suárez P, Ostrosky-Wegman P, Gallegos-Herná n dez F, et al. DNA damage in peripheral blood lymphocytes in patients during combined chemotherapy for breast cancer. Mutat Res 2008;640:8-15.
23. Nadin SB, Vargas-Roig LM, Drago G, Ibarra J, Ciocca DR. DNA damage and repair in peripheral blood lymphocytes from healthy individuals and cancer patients: a pilot study on the implications in the clinical response to chemotherapy. Cancer Lett 2006;239:84-97. (Pubitemid 43949594)
24. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia: origin and signifi cance of " carbonyl stress " in long-term uremic complications. Kidney Int 1999;55:389-399. (Pubitemid 29082866)
25. Kang D, Hamasaki N. Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes, and cancer. Curr Med Chem 2005;12:429-441. (Pubitemid 40309137)
26. Rossner P Jr, Terry MB, Gammon MD, et al. Plasma protein carbonyl levels and breast cancer risk. J Cell Mol Med 2007;11:1138-1148. (Pubitemid 350037055)
27. Kobiela J, Kubasik-Juraniec J, Stefaniak T, et al. The correlation of protein peroxidation with morphological changes in experimental oestradiol-induced carcinogenesis. Folia Morphol (Warsz) 2003;62:341-346. (Pubitemid 37527574)
28. Tesarov á P, Kalousová M, Trnkov á B, et al. Carbonyl and oxidative stress in patients with breast cancer-is there a relation to the stage of the disease? Neoplasma 2007;54:219-224.
29. Look MP, Musch E. Lipid peroxides in the polychemotherapy of cancer patients. Chemotherapy 1994;40:8-15. (Pubitemid 23360156)
30. Faber M, Coudray C, Hida H, Mousseau M, Favier A. Lipid peroxidation products and trace elements status in patients with cancer before and after chemotherapy, including adriamycin. A preliminary study. Biol Trace Elem Res 1995; 47:117-123.
31. Jałoszyński P, Kujawski M, Czub-Swierczek M, Markowska J, Szyfter K. Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by comet assay. Mutat Res 1997;385:223-233. (Pubitemid 28097311)
32. Blasiak J, Arabski M, Krupa R, et al. Basal, oxidative and alkylative DNA damage, DNA repair effi cacy and mutagen sensitivity in breast cancer. Mutat Res 2004;554:139-148. (Pubitemid 39140822)
33. Asakawa H, Koizumi H, Koike A, et al. Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins. Breast Cancer Res 2010;12:R17.
34. Serrano MJ, Nadal R, Lorente JA, et al. Circulating cancer cells in division in an early breast cancer patient. Ann Oncol 2011;22:2150-2151.